COLUMBIA, Md., May 16 /PRNewswire-FirstCall/ -- Martek Biosciences Corporation announced that it intends to release the results of its second quarter of fiscal 2007 on June 6, 2007, at approximately 4:00 p.m. Eastern Daylight Time (EDT). Following the release, at 4:45 p.m. EDT Martek will hold a conference call to discuss the results of its second quarter of fiscal 2007 with investors. The call is expected to be approximately one hour in duration. The conference call will also be available live via the Internet. All interested parties may listen to the call by visiting Martek’s web site at http://investors.martek.com .
An archive of the conference call will be available on Martek’s website for thirty days. In addition, a recorded playback of the call will be available for one week and can be accessed by calling 800-633-8284 and entering pass code 21337324.
Martek Biosciences Corporation is a leader in the innovation and development of DHA omega-3 products that promote health and wellness through every stage of life. The Company produces life’s DHA(TM), a vegetarian source of the omega-3 fatty acid DHA (docosahexaenoic acid), for use in foods, beverages, infant formula, and supplements, and ARA (arachidonic acid), an omega-6 fatty acid, for use in infant formula. For more information on Martek Biosciences, visit http://www.martek.com .
Contact: Kyle Stults Investor Relations (410) 740-0081 Cassie France-Kelly Public Relations (410) 740-0081
Martek Biosciences Corporation
CONTACT: Kyle Stults, Investor Relations, or Cassie France-Kelly, PublicRelations, both of Martek Biosciences Corporation, +1-410-740-0081
Web site: http://www.martek.com/
